12:00 AM
 | 
Jun 09, 2014
 |  BC Week In Review  |  Company News  |  Deals

Benitec Biopharma Ltd., Galapagos deal

Benitec received non-exclusive rights to European Patent No. 1444346 from Galapagos to develop Benitec's DNA-directed RNAi (ddRNAi)-based pipeline in Europe. The...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >